- Home
- HVT vs AMRN Comparison
HVT vs AMRN Comparison
Compare HVT & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HVT | AMRN |
|---|---|---|
| Founded | 1885 | 1989 |
| Country | United States | Ireland |
| Employees | 2392 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.4M | 342.8M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | HVT | AMRN |
|---|---|---|
| Price | $26.34 | $14.22 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 96.4K | 82.2K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | ★ 6.05% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $8.83 | N/A |
| Revenue Next Year | $8.70 | $1.26 |
| P/E Ratio | $22.08 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $19.53 | $12.96 |
| 52 Week High | $27.67 | $20.90 |
Technical Indicators
Market Signals| Indicator | HVT | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 68.70 | 34.47 |
| Support Level | $25.52 | $13.58 |
| Resistance Level | $27.50 | $14.49 |
| Average True Range (ATR) | 0.76 | 0.59 |
| MACD | -0.01 | -0.24 |
| Stochastic Oscillator | 87.39 | 1.86 |
Price Performance
Historical ComparisonAbout HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.